![Melissa Tosca](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Tosca
Directeur Financier/CFO chez KIORA PHARMACEUTICALS, INC.
Fortune : 17 206 $ au 31/05/2024
Postes actifs de Melissa Tosca
Sociétés | Poste | Début | Fin |
---|---|---|---|
KIORA PHARMACEUTICALS, INC. | Directeur Financier/CFO | - | - |
Corporate Officer/Principal | 13/09/2022 | - |
Historique de carrière de Melissa Tosca
Anciens postes connus de Melissa Tosca
Sociétés | Poste | Début | Fin |
---|---|---|---|
Neomorph, Inc.
![]() Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Directeur Financier/CFO | - | - |
Treasurer | - | - |
Formation de Melissa Tosca
University of Arizona | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Treasurer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Neomorph, Inc.
![]() Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Melissa Tosca
- Expérience